Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
24.8 USD | +1.43% | +1.64% | +225.03% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- CRVO Stock
- News CervoMed Inc.
- Analyst Reco.